STXS stock gains after first U.S. MAGiC procedures, marking a key milestone in robotic cardiac care and boosting its growth ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated ...

For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...

Stereotaxis (NYSE:STXS) today announced the first patients successfully treated in the U.S. with its MAGiC system.

VIENNA, Austria—For patients with persistent atrial fibrillation (AF), a hybrid approach that combines a minimally invasive surgical ablation with catheter-based radiofrequency ablation—performed ...

Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...

Demonstrating that the best solution is not always a multistage approach, a new trial showed catheter ablation is superior to a combination of antiarrhythmic drugs and lifestyle changes — weight loss, ...

Every year millions of people around the world are diagnosed with heart failure, a chronic, progressive condition where the heart is unable to pump enough oxygenated blood throughout the body.